FedEx Awards More Than $250,000 to Winners of the Ninth Annual FedEx Small Business Grant Contest

MEMPHIS, Tenn.–(BUSINESS WIRE)–FedEx Corp. (NYSE: FDX) announced today that Equine Amnio Solutions – a Texas based veterinary pharmaceutical company, is the grand prize winner of its ninth annual FedEx Small Business Grant Contest. Equine Amnio Solutions (EAS) will receive a $50,000 grant, plus $7,500 in FedEx Office® print and business services to use in the company’s mission to provide innovative products to maximize the health and performance of horses across all breeds and athletic disciplines.

“This has been an extraordinarily tough year on small business owners, which is why it’s so critical that FedEx continues to champion and support these entrepreneurs,” said Jenny Robertson, senior vice president Integrated Marketing and Communications at FedEx. “We love to see small businesses thrive, and we are incredibly proud when we can help play a role in that success.”

The Equine Amnio Solutions story began thanks to the co-founders’ love of horses, via their daughter. Ginger and Ray Johnson are longtime entrepreneurs who brought EAS to market because they have a passion for improving the lives of these animals and the humans who care for them. They plan to use the funds for ongoing clinical studies in tandem with their research and development program to launch a new product for canine use.

“We are honored to be named the 2021 FedEx Small Business Grant Contest Grand Prize Winner,” said Ginger Johnson, Equine Amnio Solutions co-founder. “RenoVō® is an advancement in regenerative medicine for equine use, and we are thrilled at the thought of helping more animals stay healthy.”

Grand Prize Winner Receives $50,000, plus $7,500 in FedEx Office print services

Equine Amnio Solutions is the market leader in the distribution of next-generation regenerative veterinary products to maximize the health and performance of horses across all breeds and athletic disciplines. One of these products, RenoVö®, has been used in over 4,000 horses and is considered a game-changing equine tissue therapy by owners and veterinarians.